Filter announcements
Loading...
Incorporated in 1986, Ortin Laboratories Ltd is engaged in the manufacturing and trading of Pharmaceuticals, Drugs and Intermediates.
ORTIN GLOBAL LIMITED has informed the Exchange regarding Notice of Annual General Meeting to be held on September 30, 2026
ORTIN GLOBAL LIMITED has informed the Exchange regarding Change in Director(s) of the company.
ORTIN GLOBAL LIMITED has informed the Exchange regarding Outcome of Board Meeting held on September 07, 2026.
Ortin Global's board has approved Q1 FY27 unaudited financial results. For the quarter ended June 30, 2026, the company reported Net Sales of 1.16 and a Net Loss after tax of -33.79. EPS came in at -0.42.
ORTIN GLOBAL LIMITED has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018